The U.S. International Trade Commission on Tuesday issued a Notice of Final Initial Determination (FID) finding that Apple violated Section 337 of the Tariff Act of 1930 by importing and selling in the United States Apple Watches with light-based pulse oximetry technology that infringed claims 24 and 30 of Masimo’s U.S. Patent No. 10,945,648. According to a Masimo press release, Apple first started selling the Apple Watch with a pulse oximeter sensor in 2020 and has continued to use it in subsequent versions of the product since then. The ITC Notice said it found no violation of the asserted claims of four other patents named in Masimo’s complaint.
Recent Posts
- PERA 2025 Debated in Senate IP Subcommittee Hearing, with Business Methods, Diagnostics in Focus
- Patent Policy in the Trump Administration: What’s Next for the USPTO? | IPWatchdog Unleashed
- If You Care About the Patent System, Consider Filing an Amicus Brief in Hyatt
- Memo to the Supreme Court: The Enablement Requirement Needs Your Guidance—Again
- Federal Circuit Rejects US Inventor Bid for Rulemaking to Limit IPR/PGR Institution